| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/27/2013 | EP2573113A2 Oxidant resistant apolipoprotein a-1 and mimetic peptides |
| 03/27/2013 | EP2573112A1 Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 03/27/2013 | EP2573111A1 GLP-1 compounds |
| 03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 03/27/2013 | EP2572730A1 Method for prevention or treatment of metabolic syndrome |
| 03/27/2013 | EP2572724A1 Treatment of fibrosis and liver diseases |
| 03/27/2013 | EP2572723A2 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 03/27/2013 | EP2572715A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572714A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572706A1 Lipid membrane structure with nuclear transferability |
| 03/27/2013 | EP2572198A1 Combination therapy and method for assessing resistance to treatment |
| 03/27/2013 | EP2572002A1 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions |
| 03/27/2013 | EP2571900A1 Improved anti-serum albumin binding variants |
| 03/27/2013 | EP2571897A1 Novel glucagon like peptide analogs, composition, and method of use |
| 03/27/2013 | EP2571896A2 Pegylated c-peptide |
| 03/27/2013 | EP2571540A1 Reinforced absorbable synthetic matrix for hemostatic applications |
| 03/27/2013 | EP2571532A2 Il-1 binding proteins |
| 03/27/2013 | EP2571531A2 Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | EP2571523A2 Latent human immunodeficiency virus reactivation |
| 03/27/2013 | EP2571517A2 Long - acting formulations of insulins |
| 03/27/2013 | EP2571516A1 Il-12 formulations for enhancing hematopoiesis |
| 03/27/2013 | EP2571515A2 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression |
| 03/27/2013 | EP2571514A1 Biglycan mutants and related therapeutics and methods of use |
| 03/27/2013 | EP2571513A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| 03/27/2013 | EP2571512A1 Novel dna-binding proteins and uses thereof |
| 03/27/2013 | EP2571511A1 New uses of oxytocin-like molecules and related methods |
| 03/27/2013 | EP2571510A1 Biosynthetic proline/alanine random coil polypeptides and their uses |
| 03/27/2013 | EP2571494A1 Hemostatic compositions |
| 03/27/2013 | EP2571360A1 Methods and formulations for oxytocin treatment of substance use, psychiatric and other disorders |
| 03/27/2013 | CN1370083B Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 03/27/2013 | CN1259141B PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 03/27/2013 | CN103003445A Method of determining the metastatic potential of a tumor |
| 03/27/2013 | CN103003303A Improved anti-serum albumin binding variants |
| 03/27/2013 | CN103003301A 血清白蛋白结合分子 Serum albumin binding molecules |
| 03/27/2013 | CN103003300A Peptide conjugates of GLP-1 receptor agonists and gastrin and their use |
| 03/27/2013 | CN103003294A Gene fusion targeted therapy |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002907A Eczema treatment |
| 03/27/2013 | CN103002906A Parathyroid hormone analogs and uses thereof |
| 03/27/2013 | CN103002905A Use of the SPARC microenvironment signature in the treatment of cancer |
| 03/27/2013 | CN103002904A Anti-angiogenic agent and method of using such agent |
| 03/27/2013 | CN103002903A Keloid treatment |
| 03/27/2013 | CN102998459A Biomarker for gastric cancer |
| 03/27/2013 | CN102994547A Recombinant human erythropoietin-CTP fusion protein production process and application |
| 03/27/2013 | CN102994407A Flavobacterium strain and incision alginate lyase coding gene, preparation and application |
| 03/27/2013 | CN102993314A Anti-tumor fusion protein, as well as preparation method and application thereof |
| 03/27/2013 | CN102993309A Human auxin fusion protein TAT-hGH as well as preparation method and application thereof |
| 03/27/2013 | CN102993289A Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof |
| 03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
| 03/27/2013 | CN102993275A Bleomycin derivatives and anti-tumour activity thereof |
| 03/27/2013 | CN102993268A Preparation method of oyster shell antioxidation peptide |
| 03/27/2013 | CN102989009A Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 03/27/2013 | CN102989001A Pegylated recombinant human growth hormone compounds |
| 03/27/2013 | CN102988995A Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT |
| 03/27/2013 | CN102988988A Pharmaceutical composition for treating pulmonary aspergillosis |
| 03/27/2013 | CN102988965A Use of ubiquitin-proteasome system in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988964A Compound growth factor as well as preparation method and application thereof |
| 03/27/2013 | CN102988963A Clinical research formula of diabetes mellitus |
| 03/27/2013 | CN102988962A Composition for preventing or treating pruritus cutanea |
| 03/27/2013 | CN102988961A Collagen scald emulsion |
| 03/27/2013 | CN102988960A Composition which promotes wound healing |
| 03/27/2013 | CN102988959A Modulation of NKG2D |
| 03/27/2013 | CN102988958A Method for preparing a factor H concentrate and the use thereof in the form of a drug |
| 03/27/2013 | CN102988957A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/27/2013 | CN102988956A Method and reagent for preventing, diagnosing, treating and prognosing bacterial infection-related diseases |
| 03/27/2013 | CN102988955A Application method of cyclic peptide compounds extracted from cortex lycii radicis |
| 03/27/2013 | CN102988954A Medicinal composition containing thymopentin compound |
| 03/27/2013 | CN102988365A Dose forms comprising VX-950 and their dosage regimen |
| 03/27/2013 | CN102988318A Orally rapidly disintegrating tablet and process for producing same |
| 03/27/2013 | CN102988295A Cell-penetrating peptide modified nanoparticle and its preparation method |
| 03/27/2013 | CN102988282A Preparation method of injection solution for improving weaned piglet intestinal tract development |
| 03/27/2013 | CN102988193A Medical beautifying polypeptide capable of promoting cell regeneration and delaying skin aging |
| 03/27/2013 | CN102335419B Health-care product for relieving fatigue |
| 03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 03/27/2013 | CN102286450B Technique for extracting active proteins from seashore mallow seeds and application thereof |
| 03/27/2013 | CN102276731B High-motion-activity polypeptide capable of inhibiting cocaine induction and application thereof |
| 03/27/2013 | CN102250233B Royal jelly polypeptide and application thereof |
| 03/27/2013 | CN102247319B Thymalfasin-containing medicinal composition and preparation method thereof |
| 03/27/2013 | CN102234638B Modified maize ribosome-inactivating protein precursor and application as well as protein purification method thereof |
| 03/27/2013 | CN102225965B Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof |
| 03/27/2013 | CN102225197B Application and extraction method of acrosin |
| 03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
| 03/27/2013 | CN102199197B Polypeptides with function of self-assembled potassium channel and its application |
| 03/27/2013 | CN102167736B Green mud crab antibacterial peptide Sphistin and application thereof |
| 03/27/2013 | CN102151329B Antitumor composition and preparation method thereof |
| 03/27/2013 | CN102140130B Antibacterial peptide and use thereof |
| 03/27/2013 | CN102139094B Application of long-chain neurotoxin of cobra in preparation of muscarine type M4 receptor activator |
| 03/27/2013 | CN102127161B Antitumor polypeptide and application thereof |
| 03/27/2013 | CN102120757B Hybrid peptide using 3S-tetrahydro-beta-carboline-3-carboxylic acid as connecting arm, and preparation method and application thereof |
| 03/27/2013 | CN102083440B Nifurtimox for treating diseases caused by trichomonadida |
| 03/27/2013 | CN102078599B Compound trimebutine maleate preparation and preparation method thereof |
| 03/27/2013 | CN102070895B Core-shell microcapsule and preparation method thereof |
| 03/27/2013 | CN102030818B Peptide inhibiting angiontensin converting enzyme |
| 03/27/2013 | CN101961314B Novel nanoemulsion drug loading system for protein drugs and preparation method thereof |
| 03/27/2013 | CN101921820B Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof |
| 03/27/2013 | CN101906464B Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/27/2013 | CN101897953B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 03/27/2013 | CN101880656B Agkistrodon halys venom thrombin and preparation method and application thereof |
| 03/27/2013 | CN101862350B Active ingredients of scorpion and application thereof |
| 03/27/2013 | CN101854937B Novel stat3 pathway inhibitors and cancer stem cell inhibitors |